Finance What to Know About This Fund’s $10 Million Nektar Bet Ahead of a Key Phase 3 LaunchMay 24, 20260 On Could 15, 2026, Prosight Administration disclosed a purchase of 180,367 shares of Nektar Therapeutics (NASDAQ:NKTR), an estimated $10.27 million…
